Shares of Pharmaceutical Stocks Are Trading Lower. The Sector May Down on Continued Weakness Amid President Trump's Drug Pricing Executive Order.

Benzinga15:27 ET

Expert Outlook: AbbVie Through The Eyes Of 10 Analysts

BenzingaMay 14 09:01 ET

AbbVie Analyst Ratings

BenzingaMay 14 08:18 ET · Ratings

Incyte And Novartis Settle Royalty Dispute With $280M Payment And 50% Reduction In Future JAKAFI U.S. Royalties, Resolving Litigation Over 2009 Collaboration Agreement And Releasing $242.2M In Accrued Liabilities

BenzingaMay 14 07:59 ET

A Look Into AbbVie Inc's Price Over Earnings

BenzingaMay 13 15:00 ET

What Does the Market Think About AbbVie?

BenzingaMay 13 11:00 ET

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

BenzingaMay 13 09:06 ET

"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".

① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.

cls.cnMay 12 20:52 ET

Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today

BenzingaMay 12 19:00 ET

AbbVie Unusual Options Activity

BenzingaMay 12 13:02 ET

The "Most-Favored-Nation Pricing" policy for Trump Medicine has been issued: benchmarked against developed countries, complete the Quote within 30 days.

① This policy aims to align prescription drug pricing in the USA with that of "Other developed countries". Trump has requested that the Quote be completed within 30 days; ② The scope of affected Pharmaceuticals is still unclear, and the White House has stated that the government will pay special attention to drugs that have the "largest price differences and highest spending"; ③ Trump had implemented a similar policy before the end of his last term, but it was blocked by the courts and ultimately fell through.

cls.cnMay 12 12:33 ET

Congressional Trading Report: Rep. Jared Moskowitz Bought Over $27K In AbbVie Stock

BenzingaMay 12 11:00 ET

Roche Plans $700M North Carolina Facility

Seeking AlphaMay 12 10:53 ET

Innovation, Pharma Profits Won't Suffer Under Trump Prescription Drug EO - White House

Seeking AlphaMay 12 10:00 ET

Trump's Drug Price Cuts: Will They Work?

Moomoo News GlobalMay 12 09:35 ET

Analyst Expectations For Insmed's Future

BenzingaMay 12 08:00 ET

Alnylam Pharma To Present Latest Data From Flagship Transthyretin Amyloidosis Franchise At Upcoming Heart Failure 2025 Congress

BenzingaMay 12 07:20 ET

United Therapeutics Corporation Filed A Complaint On May 9, 2025, In The U.S. District Court For The Middle District Of North Carolina Against Liquidia Alleging Infringement Of U.S. Patent No. 11,357,782.

BenzingaMay 12 06:13 ET

Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'

BenzingaMay 11 22:19 ET

U.S. Pharma Imports Soar in March as Drugmakers Look to Get Ahead of Potential Tariffs

Seeking AlphaMay 10 15:19 ET